Therapy of the Cognitive Deficit in Alzheimer’s Disease: The Cholinergic System
- 1 January 1991
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- The Second Generation of Cholinesterase Inhibitors: Clinical and Pharmacological EffectsPublished by Springer Nature ,1991
- Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trialDrug Development Research, 1990
- Aspects of procedural memory are differentially impaired in huntington's diseaseArchives of Clinical Neuropsychology, 1990
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- Distribution of gabaergic and cholinergic neurons in the rat diagonal bandNeuroscience, 1986
- Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's diseaseNeuroscience, 1985
- Subcellular Origin of Cholinergic Transmitter Release from Mouse BrainScience, 1980
- Cholinergic Vesicles: Ability to Empty and Refill Independently of Cytoplasmic AcetylcholineScience, 1978
- Behavioral Toxicity of Anticholinesterase Agents: Methodological, Neurochemical, and Neuropsychological AspectsPublished by Springer Nature ,1975
- DETERMINATION OF THE NUMBER, DISTRIBUTION, AND SOME IN SITU PROPERTIES OF CHOLINESTERASE MOLECULES IN THE MOTOR END PLATE, USING LABELED INHIBITOR METHODSAnnals of the New York Academy of Sciences, 1967